A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis

Journal of Pathology

Volumn 232, Issue 4, 2014, Pages 436-448

  Zhang, Shuya ^a,b   Bu, Xin ^a   Zhao, Hu ^a   Yu, Jiangtian ^a   Wang, Yingmei ^c   Li, Di ^a   Zhu, Chuchao ^a   Zhu, Tong ^a   Ren, Tingting ^a   Liu, Xinping ^a   Yao, Libo ^a   Su, Jin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

collagen receptor; DDR2; endothelial cells; tumour angiogenesis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; DISCOIDIN DOMAIN RECEPTOR 2; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GELATINASE B; MESSENGER RNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MELANOMA METASTASIS; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

COLLAGEN RECEPTOR; DDR2; ENDOTHELIAL CELLS; TUMOUR ANGIOGENESIS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENOTYPE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SKIN NEOPLASMS; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84893867273     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4311     Document Type: Article

References (47)

1. Kerbel RS,. Tumor angiogenesis. N Engl J Med 2008; 358: 2039-2049. (Pubitemid 351656458)
2. Weis SM, Cheresh DA,. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 2011; 17: 1359-1370.
3. Bergers G, Hanahan D,. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592-603.
4. Ebos JM, Lee CR, Cruz-Munoz W, et al., Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009; 15: 232-239.
5. Paez-Ribes M, Allen E, Hudock J, et al., Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220-231.
6. Conley SJ, Gheordunescu E, Kakarala P, et al., Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 2012; 109: 2784-2789.
7. Rapisarda A, Melillo G,. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat Rev Clin Oncol 2012; 9: 378-390.
8. Vogel W, Gish GD, Alves F, et al., The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997; 1: 13-23. (Pubitemid 127376389)
9. Walsh LA, Nawshad A, Medici D,. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biol 2011; 30: 243-247.
10. Badiola I, Villace P, Basaldua I, et al., Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncol Rep 2011; 26: 971-978.
11. Zhang K, Corsa CA, Ponik SM, et al., The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol 2013; 15: 677-687.
12. Valiathan RR, Marco M, Leitinger B, et al., Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metast Rev 2012; 31: 295-321.
13. Zeisberg EM, Tarnavski O, Zeisberg M, et al., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952-961. (Pubitemid 47222040)
14. Goldsmith EC, Zhang X, Watson J, et al., The collagen receptor DDR2 is expressed during early cardiac development. Anat Rec (Hoboken) 2010; 293: 762-769.
15. Katanasaka Y, Asai T, Naitou H, et al., Proteomic characterization of angiogenic endothelial cells stimulated with cancer cell-conditioned medium. Biol Pharm Bull 2007; 30: 2300-2307. (Pubitemid 350223730)
16. Kano K, Marin de Evsikova C, Young J, et al. A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol Endocrinol 2008; 22: 1866-1880.
17. Larrivee B, Karsan A,. Isolation and culture of primary endothelial cells. Methods Mol Biol 2005; 290: 315-329.
18. Zhang Y, Su J, Yu J, et al., An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J Bone Miner Res 2011; 26: 604-617.
19. Goldsmith EC, Hoffman A, Morales MO, et al., Organization of fibroblasts in the heart. Dev Dyn 2004; 230: 787-794. (Pubitemid 38993878)
20. Badiola I, Olaso E, Crende O, et al., Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut 2012; 61: 1465-1472.
21. Labrador JP, Azcoitia V, Tuckermann J, et al., The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2001; 2: 446-452. (Pubitemid 32519565)
22. Khanna C, Hunter K,. Modeling metastasis in vivo. Carcinogenesis 2005; 26: 513-523. (Pubitemid 41214139)
23. Goto F, Goto K, Weindel K, et al., Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69: 508-517. (Pubitemid 24004487)
24. Chen J, Brodsky SV, Goligorsky DM, et al., Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 2002; 90: 1290-1298. (Pubitemid 34787411)
25. Lai C, Lemke G,. Structure and expression of the Tyro 10 receptor tyrosine kinase. Oncogene 1994; 9: 877-883. (Pubitemid 24065927)
26. Olaso E, Labrador JP, Wang L, et al., Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem 2002; 277: 3606-3613. (Pubitemid 34953233)
27. Cornil I, Theodorescu D, Man S, et al., Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 1991; 88: 6028-6032. (Pubitemid 21914879)
28. Ozerdem U., Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Prostate 2006; 66: 294-304. (Pubitemid 43191229)
29. Ostman A, Heldin CH,. PDGF receptors as targets in tumor treatment. Adv Cancer Res 2007; 97: 247-274. (Pubitemid 46528991)
30. Bergers G, Song S, Meyer-Morse N, et al., Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003; 111: 1287-1295. (Pubitemid 36554699)
31. Lu C, Kamat AA, Lin YG, et al., Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res 2007; 13: 4209-4217. (Pubitemid 47105985)
32. Lu C, Shahzad MM, Moreno-Smith M, et al., Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biol Ther 2010; 9: 176-182.
33. Xian X, Hakansson J, Stahlberg A, et al., Pericytes limit tumor cell metastasis. J Clin Invest 2006; 116: 642-651. (Pubitemid 43326873)
34. Cooke VG, LeBleu VS, Keskin D, et al., Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012; 21: 66-81.
35. Chen SC, Wang BW, Wang DL, et al., Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration. Biochem Biophys Res Commun 2008; 374: 662-667.
36. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512-523.
37. Sundberg C, Ivarsson M, Gerdin B, et al., Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 1996; 74: 452-466. (Pubitemid 26072086)
38. Stratman AN, Malotte KM, Mahan RD, et al., Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009; 114: 5091-5101.
39. Augustin HG, Koh GY, Thurston G, et al., Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165-177.
40. Nakamura T, Kuwai T, Kim JS, et al., Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice. Neoplasia 2007; 9: 979-986. (Pubitemid 350086443)
41. Wang L, Luo J, He S,. Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release. BMC Cell Biol 2007; 8: 14.
42. Yao JC, Phan A,. Overcoming antiangiogenic resistance. Clin Cancer Res 2011; 17: 5217-5219.
43. Gaustad JV, Simonsen TG, Leinaas MN, et al., Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts. BMC Cancer 2012; 12: 388.
44. Lee NO, Park JW, Lee JA, et al., Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. J Cancer Res Clin Oncol 2012; 138: 73-84.
45. Tang N, Wang L, Esko J, et al., Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004; 6: 485-495. (Pubitemid 39469984)
46. Day E, Waters B, Spiegel K, et al., Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur J Pharmacol 2008; 599: 44-53.
47. Pitini V, Arrigo C, Di Mirto C, et al., Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia. Lung Cancer 2013; 82: 171-172.